帕金森病的治疗进展

被引：6

作者：

秦皎娇 ^{[1
]}

张琦 ^{[2
]}

丁斐 ^{[2
]}

机构：

[1] 南通大学医学院

[2] 南通大学神经再生重点实验室

来源：

南通大学学报(医学版) | 2015年 / 35卷 / 03期

关键词：

帕金森病; 左旋多巴; 神经保护;

D O I：

10.16424/j.cnki.cn32-1807/r.2015.03.013

中图分类号：

R742.5 [震颤麻痹综合征];

学科分类号：

1002 ;

摘要：

帕金森病是中老年人常见的神经系统退行性变。目前帕金森病的治疗主要以传统药物治疗为主,集中在对于多巴胺系统和运动症状的左旋多巴疗法,多巴胺受体激动剂和单胺氧化酶B型抑制剂也用于晚期帕金森病的辅助治疗。这些治疗虽然能控制疾病症状,却不能延缓病程。帕金森病仍然是一个导致严重残疾的持续进展性疾病,急需研究新的神经保护措施来干预其进展,为未来帕金森病的治疗提供新希望。

引用

页码：211 / 216

页数：6

共 26 条

[1]

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson’s disease[J]. Shane V.Hegarty,Gerard W.O’Keeffe,Aideen M.Sullivan.Neural Regeneration Research. 2014(19)

[2]

Autophagy and neurodegenerative disorders[J]. Evangelia Kesidou,Roza Lagoudaki,Olga Touloumi,Kyriaki-Nefeli Poulatsidou,Constantina Simeonidou.Neural Regeneration Research. 2013(24)

[3]

Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson’s disease[J] . Elpida Tsika,An Phu Tran Nguyen,Julien Dusonchet,Philippe Colin,Bernard L. Schneider,Darren J. Moore.Neurobiology of Disease . 2015

[4]

The Acetylcholine Index: An Electroencephalographic Marker of Cholinergic Activity in the Living Human Brain Applied to Alzheimer’s Disease and Other Dementias[J] . Magnus Johannsson,Jon Snaedal,Gisli Holmar Johannesson,Thorkell Eli Gudmundsson,Kristinn Johnsen.Dementia and Geriatric Cognitive Disorders . 2015 (3-4)

[5]

Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation[J] . Allon Goldberg,Catherine L. Curtis,Jeffrey A. Kleim.Journal of Neurologic Physical Therapy . 2015 (1)

[6] Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease [J].

Schaeffer, Eva ;

Pilotto, Andrea ;

Berg, Daniela .

CNS DRUGS, 2014, 28 (12) :1155-1184

[7] Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress [J].

Pangeni, Rudra ;

Sharma, Shrestha ;

Mustafa, Gulam ;

Ali, Javed ;

Baboota, Sanjula .

NANOTECHNOLOGY, 2014, 25 (48)

[8] The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease [J].

Ji, Hong-Fang ;

Shen, Liang .

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) :369-373

[9] Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease [J].

Olanow, C. Warren ;

Kieburtz, Karl ;

Rascol, Olivier ;

Poewe, Werner ;

Schapira, Anthony H. ;

Emre, Murat ;

Nissinen, Helena ;

Leinonen, Mika ;

Stocchi, Fabrizio .

MOVEMENT DISORDERS, 2013, 28 (08) :1064-1071

[10]

Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease[J] . Diego Santos-García,Raúl de la Fuente-Fernández.Journal of the Neurological Sciences . 2013

← 1 2 3 →